As we delve deep into countless medical journals to uncover the latest on Integrative Medicine’s approach to kidney health, we are always reminded of the value of your time. Our commitment remains steadfast in curating and succinctly summarizing these vital studies for you. Welcome to the August Research and News.
Nutrition in Kidney Health
Does a High-Protein Diet Harm Healthy Kidneys?
This prospective study followed 1,324 middle-aged and older adults without chronic kidney disease for a median of 10 years to examine whether habitual protein intake affected kidney function.
Unlike previous studies that relied on estimated GFR, researchers measured kidney function directly using iohexol clearance, a gold-standard method.
Participants consuming the highest amounts of protein (≥1.4 g/kg/day) did not experience faster declines in measured GFR, greater risk of accelerated kidney function loss, or a higher likelihood of developing CKD compared with those consuming less protein.
Why is this important?
High-protein diets are often thought to damage healthy kidneys because they increase glomerular filtration, but this long-term study suggests that higher habitual protein intake does not accelerate kidney function decline in adults without CKD.
These findings provide reassurance for healthy individuals consuming moderate-to-high protein diets, while reinforcing that recommendations to restrict protein should remain focused on patients with established chronic kidney disease rather than the general population.
Weight Loss Offers Multiple Benefits for Patients With CKD and Obesity
This systematic review and meta-analysis evaluated 42 randomized controlled trials involving more than 11,000 adults with chronic kidney disease (CKD) and overweight or obesity.
Lifestyle interventions, incretin-based medications, and bariatric surgery all resulted in significant weight loss and improvements in body composition.
Incretin-based therapies reduced urine albumin-to-creatinine ratio by 41%, suggesting important kidney-protective effects, while bariatric surgery significantly improved eGFR.
Lifestyle interventions produced modest reductions in blood pressure, although evidence for cardiovascular outcomes and mortality remains limited.
Why is this important?
Obesity is a major modifiable risk factor for CKD progression and cardiovascular disease. This analysis reinforces that intentional weight loss can improve several key kidney and metabolic outcomes, with incretin-based therapies and bariatric surgery showing particularly promising renal benefits.
As newer anti-obesity medications become more widely available, weight management is increasingly becoming an important component of comprehensive CKD care.
Gut-Kidney Connection
Blocking a Gut Microbial Toxin Reversed Kidney Disease in Mice
This preclinical study investigated whether inhibiting production of trimethylamine N-oxide (TMAO), a gut microbe-derived metabolite linked to chronic kidney disease (CKD), could reverse established kidney damage.
Mice with CKD were treated with fluoromethylcholine (FMC), a selective inhibitor of microbial TMAO production, after kidney disease had already developed.
FMC nearly eliminated circulating TMAO levels, improved glomerular filtration rate by 39%, lowered creatinine, cystatin C, albuminuria, and multiple uremic toxins, and reduced kidney fibrosis by 41%.
Rather than simply slowing disease progression, treatment produced measurable regression of kidney dysfunction and structural damage.
Why is this important?
Most current CKD therapies focus on slowing disease progression rather than reversing existing damage. This study suggests that targeting gut microbial TMAO production may represent a novel therapeutic strategy capable of not only halting CKD progression but also promoting recovery of kidney function and fibrosis.
Although these findings are limited to animal models, they further strengthen the growing evidence that the gut microbiome plays a central role in CKD and could become an important target for future kidney therapies.
Lifestyle and Kidney Health
Diabetes Is Becoming an Even Bigger Driver of Chronic Kidney Disease
An analysis of more than 25,000 U.S. adults from the National Health and Nutrition Examination Survey (NHANES) found that the overall prevalence of chronic kidney disease (CKD) remained essentially unchanged between 2013–2014 and 2021–2023, affecting approximately 14.8% of U.S. adults, or an estimated 36 million people.
However, the causes of CKD shifted during this period, with diabetes-related CKD increasing from 4.7% to 5.7%. Diabetes and heart failure were the conditions most strongly associated with CKD, while blood pressure control, glycemic management, and use of kidney-protective therapies remained suboptimal.
Albuminuria was more common than reduced eGFR as the initial marker of CKD, highlighting its value for early detection.
Why is this important?
Despite the availability of newer kidney-protective therapies such as SGLT2 inhibitors and finerenone, the overall burden of CKD has not declined.
These findings emphasize that preventing CKD requires earlier diagnosis and more aggressive management of diabetes and cardiovascular disease, along with routine albuminuria screening in high-risk patients.
The growing overlap between diabetes, heart disease, and CKD also reinforces the need for an integrated cardiovascular-kidney-metabolic (CKM) approach to patient care.
Join us to end the kidney disease epidemic
Genetics and Epigenetics
Your Genes May Determine How Your Diet Affects Your Kidneys
This study investigated whether genetic risk influences how diet affects kidney function in 5,717 generally healthy adults from the CHRIS study. Researchers combined a polygenic risk score for reduced kidney function with assessments of dietary quality and nutrient intake.
While genetic risk was consistently associated with lower estimated glomerular filtration rate (eGFR), higher protein and phosphorus intake appeared to have a stronger negative association with kidney function in people with a greater genetic predisposition to CKD.
In contrast, overall dietary patterns such as the Mediterranean, DASH, and Healthy Eating Index were not significantly modified by genetic risk.
Why is this important?
These findings suggest that genetics may influence how susceptible a person is to the effects of dietary protein and phosphorus on kidney health.
Although the results are exploratory and need confirmation in larger studies, they support the growing concept of precision nutrition, where dietary recommendations could one day be tailored not only to kidney function but also to an individual’s genetic risk profile.
Review article of the month
Can Last Night’s Steak Make Your Kidney Function Look Worse?
This review highlights an important but often overlooked limitation of creatinine-based kidney function testing: eating cooked meat, poultry, or fish before a blood draw can temporarily raise serum creatinine and falsely lower estimated glomerular filtration rate (eGFR).
The authors explain that cooking converts creatine in animal muscle into creatinine, which is rapidly absorbed after ingestion and can increase serum creatinine by 8% to 52% for up to 12–24 hours without any true change in kidney function.
Because cystatin C is unaffected, the review emphasizes its value when creatinine measurements may be confounded. The authors also discuss how dietary patterns, including high-protein and ketogenic diets, as well as differences in meat consumption across populations, may contribute to variability in creatinine-based kidney function estimates.
They conclude that greater awareness of recent dietary intake and more standardized pre-test instructions could improve the accuracy of CKD diagnosis, staging, and monitoring.
Join here to receive FREE monthly updates on the latest research in Integrative Nephrology and tips on managing kidney disease straight to your inbox.
We would love to hear your feedback. Let us know what you think of these educational materials and if you would like us to focus on specific topics. Please email us at info@inkidney.com.
